The Antipsychotics Market Insight & Analysis 2008
Topics: CNS/Neurology, Behavioral Health
|
Offices of Mental Health Practitioners (except Physicians) in the US - Industry Risk Rating Report
Topics: Physicians' Offices, Behavioral Health
Regions: United States
|
Outpatient Mental Health and Substance Abuse Centers in the US - Industry Risk Rating Report
Topics: Services, Behavioral Health
Regions: United States
|
Residential Mental Health and Substance Abuse Facilities in the US - Industry Risk Rating Report
Topics: Facilities, Behavioral Health
Regions: United States
|
Psychiatric and Substance Abuse Hospitals in the US - Industry Risk Rating Report
Topics: Hospitals & Clinics, Behavioral Health
Regions: United States
|
Plimsoll Portfolio Analysis - Mental Health Centres (UK)
Topics: Facilities Company Reports, Behavioral Health
|
Pipeline Insight: Substance Dependence - Part II: Alcohol
Topics: Drug Discovery, Behavioral Health
|
Outpatient Mental Health and Substance Abuse Centers in the US - Industry Market Research Report
Topics: Facilities, Behavioral Health
|
Global Smoking Cessation Market Analysis & Forecasts - Preparing for the First Blockbuster
Topics: Pharmaceuticals, Over-the-Counter Drugs, Prescription Drugs, Behavioral Health, Smoking Cessation
Regions: Global
|
Commercial Insight: Depression - Atypical Lifecycle Management Strategy Rejuvenates Depression Market
Topics: Prescription Drugs, Drug Discovery, CNS/Neurology, Behavioral Health
|
Conference Documentation: Depression & Anxiety
Topics: Drug Discovery, Behavioral Health
|
The Neurotechnology Industry 2007 Report: Drugs, Devices and Diagnostics for the Brain and Nervous System
Topics: Obesity, Pain, Alzheimer's Disease, Medical Devices, CNS/Neurology, Behavioral Health
|
Offices of Mental Health Practitioners (except Physicians) in the US - Industry Market Research Report
Topics: Facilities, Behavioral Health
Regions: United States
|
Psychiatric and Substance Abuse Hospitals in the US - Industry Market Research Report
Topics: Hospitals & Clinics, Behavioral Health
|
Smoking Cessation and Addiction Treatments: A World Market Analysis
Topics: Wellness/Prevention Programs, Pharmaceuticals, Prescription Drugs, Respiratory/Pulmonary, Behavioral Health, Smoking Cessation
Regions: Global
|
Residential Mental Health and Substance Abuse Facilities in the US - Industry Market Research Report
Topics: Facilities, Behavioral Health
Regions: United States
|
Bipolar Disorder: Can Competitive Advantage Be Established in a Challenging Market
Topics: CNS/Neurology, Behavioral Health
Regions: United States
|
Pipeline Insight: Depression - Novel drugs to grow third-line market
Topics: CNS/Neurology, Behavioral Health
|
Psychiatric & Other Specialist Hospital Services in Indonesia
Topics: Facilities, Behavioral Health
Regions: Indonesia
|
Disease and Therapy Review: Bipolar Disorder
Topics: CNS/Neurology, Behavioral Health
Regions: Global
|
Psychotherapeutics: Antidepressants, Antipsychotics, Antianxiety Drugs, World Market
Topics: Research & Development, Prescription Drugs, CNS/Neurology, Behavioral Health
Regions: Global
|
Disease and Therapy Review: Major Depressive Disorder
Topics: Prescription Drugs, Behavioral Health
Regions: Global
|
Atypical Antipsychotics: Life-Cycle Management and Future Trends
Topics: Pharmaceuticals, Prescription Drugs, CNS/Neurology, Behavioral Health
|
CNS Drug Discoveries: Attention Deficit Hyperactivity Disorder (ADHD) Chapter
Topics: Prescription Drugs, Drug Discovery, CNS/Neurology, Behavioral Health
|
Anti-addiction Therapies, 2006-2011 - The Pharmaceutical Industry’s Next Viagra?
Topics: Pharmaceuticals, Research & Development, CNS/Neurology, Behavioral Health, Smoking Cessation
|
The 2007-2012 Outlook for Psychotherapeutic Agents Excluding Tranquilizers and Antidepressants in the United States
Topics: Prescription Drugs, Behavioral Health
Regions: United States
|
The 2007-2012 Outlook for Psychotherapeutic Antidepressant Agents in the United States
Topics: Prescription Drugs, Behavioral Health
Regions: United States
|
The 2007-2012 Outlook for Antidepressant Pharmaceuticals in the United States
Topics: Manufacturing, Packaging & Detailing, Prescription Drugs, CNS/Neurology, Behavioral Health
Regions: United States
|
The 2007-2012 Outlook for Psychotherapeutic Tranquilizing Agents Excluding Phenothiazine Derivatives in the United States
Topics: Prescription Drugs, Behavioral Health
|
Worldwide Psychotherapeutic Drug Market
Topics: Pharmaceuticals, Behavioral Health
Regions: Global
|
Residential Mental Health and Substance Abuse Facilities in the US
Topics: Facilities, Behavioral Health
Regions: United States
|
Pipeline Insight: Bipolar Disorder - New Treatments for Bipolar Depression Set to Drive Near-term Growth
Topics: Research & Development, Prescription Drugs, CNS/Neurology, Behavioral Health
|
Conference Documentation: Depression & Anxiety
Topics: Prescription Drugs, Drug Discovery, Behavioral Health
|
European Antidepressants Markets
Topics: Behavioral Health
Regions: Europe
|
The 2007-2012 World Outlook for Psychotherapeutic Antidepressant Agents
Topics: Prescription Drugs, Behavioral Health
Regions: Global
|
The 2007-2012 World Outlook for Psychotherapeutic Tranquilizing Agents Excluding Phenothiazine Derivatives
Topics: Prescription Drugs, Behavioral Health
Regions: Global
|
Stakeholder Insight: Major Depressive Disorder - Duloxetine - Fulfilling An Unmet Need?
Topics: Prescription Drugs, Behavioral Health
|
Pipeline Insight: Anxiety Disorders - A Decade of Declining Revenues
Topics: Drug Discovery, Behavioral Health
|
Residential Mental Retardation Facilities in the US
Topics: Behavioral Health
Regions: United States
|
Sleeper Diseases: Forecast and Assessment of Neglected Disease Market Opportunities
Topics: Diseases & Conditions, Respiratory/Pulmonary, Behavioral Health
|
Antidepressants
Topics: Prescription Drugs, Behavioral Health
Regions: Global
|
Residential Mental Retardation Facilities in the US - Industry Market Research Report
Topics: Facilities, Behavioral Health
Regions: United States
|
Impact of Generics on the Antidepressant Market
Topics: Pharmaceuticals, Generics Drugs, Prescription Drugs, Behavioral Health
|
Residential Mental Health and Substance Abuse Facilities in the US
Topics: Facilities, Behavioral Health
Regions: United States
|
Opportunities and Challenges in the Adult Attention-Deficit/Hyperactivity Disorder Market
Topics: Behavioral Health
|
Psychopharmacotherapy Market Insights: Obstacles and Opportunities in Mood Disorders and Cognitive Impairment, 2005-2012
Topics: Prescription Drugs, CNS/Neurology, Behavioral Health
Regions: United States, Global
|
Residential Mental Retardation Facilities in the US
Topics: Facilities, Behavioral Health
Regions: United States
|
The World Market for Antidepressants, 2006
Topics: Prescription Drugs, Behavioral Health
|
Emotional and Behavioral Disorders in Children and Adolescents
Topics: Children, Teens (13-19), Behavioral Health
|
Commercial Insight: ADHD - Strattera Reigns Supreme as Branded Stimulants Slump
Topics: Behavioral Health
|
